Supporting the role of penile trauma and micro-trauma in the etiology of Peyronie’s disease. Prospective observational study using the electronic microscope to examine two types of plaques

Abstract Objectives The etiopathogenesis of Peyronie’s disease (PD) remains not clearly understood. The most accepted theory attributes the histological lesions of PD to the effects of trauma to the corpora cavernosum of the penis. The aim of our study is to verify whether similar histological features exist between these two tissues, providing new evidence in favor of the traumatic theory in the etiopathogenesis of Peyronie’s disease. Materials and methods A prospective observational study was carried out at our institution from January 2013 to June 2018, involving patients having undergone surgery for PD and those with delayed surgery for penile trauma. Both excised PD and post-traumatic plaques were analyzed by blind pathologists with an 80kV potential acceleration electron microscope. Results Five patients were identified with a post-traumatic plaque (Group 1) and therefore an equal number of PD patients were enrolled for Group 2. The ultrastructural characteristics of the two types of preparations were very similar. In all the samples we showed an inflammatory reaction of the structure of the tunica albuginea, a production of the disorganized extracellular matrix, a proliferation of inflammatory cells and fibroblasts. Furthermore, we have found an increase in the density and collagen deposits grouped in the extracellular space and within the fibroblasts. Conclusions These findings support the theory that attributes lesions and symptoms typical of PD to the effects of cavernous body trauma.

[1]  M. Gunes,et al.  Levels of serum trace elements in patients with Peyronie , 2020, The aging male : the official journal of the International Society for the Study of the Aging Male.

[2]  Ji-sheng Wang,et al.  Research of stroke combined hyperlipidemia-induced erectile dysfunction in rat model , 2018, The aging male : the official journal of the International Society for the Study of the Aging Male.

[3]  K. Kokk,et al.  Expression of LHCG receptors in the human penis , 2018, The aging male : the official journal of the International Society for the Study of the Aging Male.

[4]  K. Mohanraj,et al.  Therapeutic potential of Mucuna pruriens (Linn.) on ageing induced damage in dorsal nerve of the penis and its implication on erectile function: an experimental study using albino rats , 2018, The aging male : the official journal of the International Society for the Study of the Aging Male.

[5]  S. Sikka,et al.  Aging and sexual health: getting to the problem , 2017, The aging male : the official journal of the International Society for the Study of the Aging Male.

[6]  S. Binsaleh,et al.  Association of the modified frailty index with adverse outcomes after penile prosthesis implantation , 2017, The aging male : the official journal of the International Society for the Study of the Aging Male.

[7]  M. Vukovic,et al.  Vacuum erection device in treatment of organic erectile dysfunction and penile vascular differences between patients with DM type I and DM type II , 2017, The aging male : the official journal of the International Society for the Study of the Aging Male.

[8]  A. Al-Ansari,et al.  RigiScan data under long-term testosterone therapy: improving long-term blood circulation of penile arteries, penile length and girth, erectile function, and nocturnal penile tumescence and duration , 2016, The aging male : the official journal of the International Society for the Study of the Aging Male.

[9]  R. Lewis,et al.  Plication procedures—excisional and incisional corporoplasty and imbrication for Peyronie’s disease , 2016, Translational andrology and urology.

[10]  A. Pastuszak,et al.  Peyronie’s Disease: A Review of Etiology, Diagnosis, and Management , 2015, Current Sexual Health Reports.

[11]  Xiaolei Zhou,et al.  A Population-Based Study of Peyronie's Disease: Prevalence and Treatment Patterns in the United States , 2011, Advances in urology.

[12]  A. Morgentaler,et al.  Testosterone deficiency and Peyronie's disease: pilot data suggesting a significant relationship. , 2009, The journal of sexual medicine.

[13]  J. Marinković,et al.  Risk factors for Peyronie's disease: a case‐control study , 2006, BJU international.

[14]  R. Dahiya,et al.  The effect of surgical trauma on rat tunica albuginea. , 1998, The Journal of urology.

[15]  N. Martinet,et al.  The role of cytokines in human lung fibrosis. , 1996, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[16]  T. Yoshimoto,et al.  Thrombin and TGF-β promote human leptomeningeal cell proliferation in vitro , 1995, Neuroscience Letters.

[17]  L. Lenke,et al.  Astrocyte Response and Transforming Growth Factor‐&bgr; Localization in Acute Spinal Cord Injury , 1994, Spine.

[18]  E. Castrén,et al.  Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation , 1992, The Journal of cell biology.

[19]  P. Grambsch,et al.  The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. , 1991, The Journal of urology.

[20]  D. Cohen,et al.  Polarized regulation of fibronectin secretion and alternative splicing by transforming growth factor. , 1991, The Journal of biological chemistry.

[21]  F. Dorey,et al.  The natural history of Peyronie's disease. , 1990, The Journal of urology.

[22]  George L. Wright,et al.  Isolation and characterization of collagen in Peyronie's disease. , 1989, The Journal of urology.

[23]  L M Wakefield,et al.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Dini,et al.  Intracellular collagen in fibroblasts of Peyronie's disease. , 1986, Journal of submicroscopic cytology.

[25]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Sporn,et al.  Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth , 1986, The Journal of experimental medicine.

[27]  Smith Bh Subclinical Peyronie's disease. , 1969 .

[28]  Edward B. Smith Pathology of Leukemia , 1969 .

[29]  A. Traish,et al.  Long‐Term Testosterone Therapy Improves Urinary and Sexual Function, and Quality of Life in Men with Hypogonadism: Results from a Propensity Matched Subgroup of a Controlled Registry Study , 2018, The Journal of urology.

[30]  A. Kadıoğlu,et al.  Peyronie's disease surgery: Surgical outcomes of 268 cases. , 2018, Turkish journal of urology.

[31]  O. Motohashi,et al.  Thrombin and TGF-beta promote human leptomeningeal cell proliferation in vitro. , 1995, Neuroscience letters.

[32]  L. Zardi,et al.  Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. , 1988, FEBS letters.

[33]  J. V. Vande Berg,et al.  Mechanisms of calcification in Peyronie's disease. , 1982, The Journal of urology.

[34]  B. H. Smith,et al.  Subclinical Peyronie's disease. , 1969, American journal of clinical pathology.